Terms: = Breast cancer AND STIL, SIL, 6491, ENSG00000123473, Q15468
131 results:
1. Tumor-infiltrating lymphocytes and breast cancer mortality in racially and ethnically diverse participants of the Northern California breast cancer Family Registry.
Ransohoff JD; Miller I; Koo J; Joshi V; Kurian AW; Allison KH; John EM; Telli ML
JNCI Cancer Spectr; 2024 Feb; 8(2):. PubMed ID: 38547391
[TBL] [Abstract] [Full Text] [Related]
2. Long-term outcomes of young, node-negative, chemotherapy-naïve, triple-negative breast cancer patients according to BRCA1 status.
Wang Y; Dackus GMHE; Rosenberg EH; Cornelissen S; de Boo LW; Broeks A; Brugman W; Chan TWS; van Diest PJ; Hauptmann M; Ter Hoeve ND; Isaeva OI; de Jong VMT; Jóźwiak K; Kluin RJC; Kok M; Koop E; Nederlof PM; Opdam M; Schouten PC; Siesling S; van Steenis C; Voogd AC; Vreuls W; Salgado RF; Linn SC; Schmidt MK
BMC Med; 2024 Jan; 22(1):9. PubMed ID: 38191387
[TBL] [Abstract] [Full Text] [Related]
3. Treatment Response, Tumor Infiltrating Lymphocytes and Clinical Outcomes in Inflammatory breast cancer-Treated with Neoadjuvant Systemic Therapy.
De Schepper M; Nguyen HL; Richard F; Rosias L; Lerebours F; Vion R; Clatot F; Berghian A; Maetens M; Leduc S; Isnaldi E; Molinelli C; Lambertini M; Grillo F; Zoppoli G; Dirix L; Punie K; Wildiers H; Smeets A; Nevelsteen I; Neven P; Vincent-Salomon A; Larsimont D; Duhem C; Viens P; Bertucci F; Biganzoli E; Vermeulen P; Floris G; Desmedt C
Cancer Res Commun; 2024 Jan; 4(1):186-199. PubMed ID: 38147006
[TBL] [Abstract] [Full Text] [Related]
4. The Role of Stromal Tumour Infiltrating Lymphocytes (stil) Intensity and Programmed Death Ligand 1 () Expression in breast cancer Response to Neoadjuvant Therapy in Cipto Mangunkusumo Hospital (CMH), Indonesia.
Rustamadji P; Felicia D; Wuyung PE; Hellyanti T
Asian Pac J Cancer Prev; 2023 Oct; 24(10):3459-3465. PubMed ID: 37898851
[TBL] [Abstract] [Full Text] [Related]
5. Spatial analyses of immune cell infiltration in cancer: current methods and future directions: A report of the International Immuno-Oncology Biomarker Working Group on breast cancer.
Page DB; Broeckx G; Jahangir CA; Verbandt S; Gupta RR; Thagaard J; Khiroya R; Kos Z; Abduljabbar K; Acosta Haab G; Acs B; Akturk G; Almeida JS; Alvarado-Cabrero I; Azmoudeh-Ardalan F; Badve S; Baharun NB; Bellolio ER; Bheemaraju V; Blenman KR; Botinelly Mendonça Fujimoto L; Bouchmaa N; Burgues O; Cheang MCU; Ciompi F; Cooper LA; Coosemans A; Corredor G; Dantas Portela FL; Deman F; Demaria S; Dudgeon SN; Elghazawy M; Ely S; Fernandez-Martín C; Fineberg S; Fox SB; Gallagher WM; Giltnane JM; Gnjatic S; Gonzalez-Ericsson PI; Grigoriadis A; Halama N; Hanna MG; Harbhajanka A; Hardas A; Hart SN; Hartman J; Hewitt S; Hida AI; Horlings HM; Husain Z; Hytopoulos E; Irshad S; Janssen EA; Kahila M; Kataoka TR; Kawaguchi K; Kharidehal D; Khramtsov AI; Kiraz U; Kirtani P; Kodach LL; Korski K; Kovács A; Laenkholm AV; Lang-Schwarz C; Larsimont D; Lennerz JK; Lerousseau M; Li X; Ly A; Madabhushi A; Maley SK; Manur Narasimhamurthy V; Marks DK; McDonald ES; Mehrotra R; Michiels S; Minhas FUAA; Mittal S; Moore DA; Mushtaq S; Nighat H; Papathomas T; Penault-Llorca F; Perera RD; Pinard CJ; Pinto-Cardenas JC; Pruneri G; Pusztai L; Rahman A; Rajpoot NM; Rapoport BL; Rau TT; Reis-Filho JS; Ribeiro JM; Rimm D; Vincent-Salomon A; Salto-Tellez M; Saltz J; Sayed S; Siziopikou KP; Sotiriou C; Stenzinger A; Sughayer MA; Sur D; Symmans F; Tanaka S; Taxter T; Tejpar S; Teuwen J; Thompson EA; Tramm T; Tran WT; van der Laak J; van Diest PJ; Verghese GE; Viale G; Vieth M; Wahab N; Walter T; Waumans Y; Wen HY; Yang W; Yuan Y; Adams S; Bartlett JMS; Loibl S; Denkert C; Savas P; Loi S; Salgado R; Specht Stovgaard E
J Pathol; 2023 Aug; 260(5):514-532. PubMed ID: 37608771
[TBL] [Abstract] [Full Text] [Related]
6. The clinical efficacy of Apatinib plus Ba Zhen granules in the treatment of advanced unresectable differentiated thyroid cancer and their influence on immune factors.
Bai Y; Jin J; Liu Y; Zhang B; Li J
Pak J Pharm Sci; 2023 May; 36(3(Special)):935-939. PubMed ID: 37587701
[TBL] [Abstract] [Full Text] [Related]
7. Characterization and spatial distribution of the immune cell infiltrate in triple-negative breast cancer: a novel classification based on plasma cells and CD8+ T cells.
Gonzàlez-Farré M; Gibert J; Santiago-Díaz P; Menéndez S; Monzonis X; Olivares F; Riera X; López D; Torner A; Casado B; Bellosillo B; Lloveras B; Casadevall D; Rovira A; Servitja S; Albanell J; Vázquez I; Comerma L
Hum Pathol; 2023 Sep; 139():91-105. PubMed ID: 37517596
[TBL] [Abstract] [Full Text] [Related]
8. Automated quantification of stromal tumour infiltrating lymphocytes is associated with prognosis in breast cancer.
Gonzàlez-Farré M; Gibert J; Santiago-Díaz P; Santos J; García P; Massó J; Bellosillo B; Lloveras B; Albanell J; Vázquez I; Comerma L
Virchows Arch; 2023 Nov; 483(5):655-663. PubMed ID: 37500796
[TBL] [Abstract] [Full Text] [Related]
9. Genomics of
Lipsyc-Sharf M; Jain E; Collins LC; Rosenberg SM; Ruddy KJ; Tamimi RM; Schapira L; Come SE; Peppercorn JM; Borges VF; Warner E; Snow C; Krop IE; Kim D; Weiss J; Zanudo JGT; Partridge AH; Wagle N; Waks AG
JCO Precis Oncol; 2023 Jun; 7():e2300076. PubMed ID: 37364233
[TBL] [Abstract] [Full Text] [Related]
10. Association Between Biomarkers and Clinical Outcomes of Pembrolizumab Monotherapy in Patients With Metastatic Triple-Negative breast cancer: KEYNOTE-086 Exploratory Analysis.
Loi S; Salgado R; Schmid P; Cortes J; Cescon DW; Winer EP; Toppmeyer DL; Rugo HS; De Laurentiis M; Nanda R; Iwata H; Awada A; Tan AR; Sun Y; Karantza V; Wang A; Huang L; Saadatpour A; Cristescu R; Yearley J; Lunceford J; Jelinic P; Adams S
JCO Precis Oncol; 2023 Apr; 7():e2200317. PubMed ID: 37099733
[TBL] [Abstract] [Full Text] [Related]
11. A maladaptive pleural environment suppresses preexisting anti-tumor activity of pleural infiltrating T cells.
Donnenberg VS; Luketich JD; Sultan I; Lister J; Bartlett DL; Ghosh S; Donnenberg AD
Front Immunol; 2023; 14():1157697. PubMed ID: 37063842
[TBL] [Abstract] [Full Text] [Related]
12. Tumour Infiltrating Lymphocytes (TILs) and immune composition in breast cancer patients from Kenya: Spatial distributions and associations with risk factors and tumour characteristics.
Sayed S; Koka H; Abubakar M; Gardner K; Salgado R; Moloo Z; Caban-Ureña AB; Rosen D; Castro P; Saleh M; Shaikh AJ; Shah J; Figueroa J; Makokha F; Ha HK; Wang Z; Magangane P; Naidoo R; Ngundo V; Yang XR; Govender D
Breast Cancer Res Treat; 2023 Jun; 199(2):401-413. PubMed ID: 37010652
[TBL] [Abstract] [Full Text] [Related]
13. LAG-3 expression in tumor microenvironment of triple-negative breast cancer.
Tahtacı G; Günel N; Sadioğlu A; Akyürek N; Boz O; Üner A
Turk J Med Sci; 2023 Feb; 53(1):142-148. PubMed ID: 36945923
[TBL] [Abstract] [Full Text] [Related]
14. Mendelian Randomization Study on Causal Association of IL-6With breast cancer.
Zhang M; Ma N; Wang R
Clin Breast Cancer; 2023 Jun; 23(4):e182-e188. PubMed ID: 36813657
[TBL] [Abstract] [Full Text] [Related]
15. Facts and Hopes in Immunotherapy for Early-Stage Triple-Negative breast cancer.
Nederlof I; Voorwerk L; Kok M
Clin Cancer Res; 2023 Jul; 29(13):2362-2370. PubMed ID: 36622327
[TBL] [Abstract] [Full Text] [Related]
16. Therapeutic yoga reduces pro-tumorigenic cytokines in cancer survivors.
Patel DI; Almeida GJ; Darby NT; Serra MC; Calderon T; Lapetoda A; Gutierrez B; Ramirez AG; Hughes DC
Support Care Cancer; 2022 Dec; 31(1):33. PubMed ID: 36517621
[TBL] [Abstract] [Full Text] [Related]
17. Tumor P70S6K hyperactivation is inversely associated with tumor-infiltrating lymphocytes in triple-negative breast cancer.
Jimeno R; Mouron S; Salgado R; Loi S; Pérez-Mies B; Sánchez-Bayona R; Manso L; Martínez M; Garrido-García A; Serrano-Pardo R; Colomer R; Quintela-Fandino M
Clin Transl Oncol; 2023 Apr; 25(4):1124-1131. PubMed ID: 36508123
[TBL] [Abstract] [Full Text] [Related]
18. Impact of RNA Signatures on pCR and Survival after 12-Week Neoadjuvant Pertuzumab plus Trastuzumab with or without Paclitaxel in the WSG-ADAPT HER2+/HR- Trial.
Graeser M; Gluz O; Biehl C; Ulbrich-Gebauer D; Christgen M; Palatty J; Kuemmel S; Grischke EM; Augustin D; Braun M; Potenberg J; Wuerstlein R; Krauss K; Schumacher C; Forstbauer H; Reimer T; Stefek A; Fischer HH; Pelz E; Zu Eulenburg C; Kates R; Ni H; Kolberg-Liedtke C; Feuerhake F; Kreipe HH; Nitz U; Harbeck N
Clin Cancer Res; 2023 Feb; 29(4):805-814. PubMed ID: 36441798
[TBL] [Abstract] [Full Text] [Related]
19. Targeted Proteomic Analysis of Small GTPases in Radioresistant breast cancer Cells.
Gao Z; Yang YY; Huang M; Qi TF; Wang H; Wang Y
Anal Chem; 2022 Nov; 94(43):14925-14930. PubMed ID: 36264766
[TBL] [Abstract] [Full Text] [Related]
20. Mesoporous silica coated SPIONs containing curcumin and silymarin intended for breast cancer therapy.
Sadegha S; Varshochian R; Dadras P; Hosseinzadeh H; Sakhtianchi R; Mirzaie ZH; Shafiee A; Atyabi F; Dinarvand R
Daru; 2022 Dec; 30(2):331-341. PubMed ID: 36197594
[TBL] [Abstract] [Full Text] [Related]
[Next]
